A Case of Primary Antiphospholipid Syndrome with Pulmonary Thromboembolism
![]() ![]() |
Lee, Jae Beom
(Department of Internal Medicine, College of Medicine, Ewha Womans University)
Sim, Yun Su (Department of Internal Medicine, College of Medicine, Ewha Womans University) Noh, Young Wook (Department of Internal Medicine, College of Medicine, Ewha Womans University) Park, Hye Sung (Department of Internal Medicine, College of Medicine, Ewha Womans University) Tae, Chung Hyun (Department of Internal Medicine, College of Medicine, Ewha Womans University) Lim, So Yeon (Department of Internal Medicine, College of Medicine, Ewha Womans University) Jun, Yoon Hee (Department of Internal Medicine, College of Medicine, Ewha Womans University) Ryu, Yon Ju (Department of Internal Medicine, College of Medicine, Ewha Womans University) Chun, Eun Mi (Department of Internal Medicine, College of Medicine, Ewha Womans University) Lee, Jin Hwa (Department of Internal Medicine, College of Medicine, Ewha Womans University) Chang, Jung Hyun (Department of Internal Medicine, College of Medicine, Ewha Womans University) Moon, Jin Wook (Department of Internal Medicine, College of Medicine, Ewha Womans University) |
1 | Sandoval J, Amigo MC, Barragan R, Izaguirre R, Reyes PA, Martinez-Guerra ML, et al. Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy. J Rhumatol 1996;23: 772-5 |
2 | Stojanovich L. Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 2006;5:344-8 DOI ScienceOn |
3 | Cherian J, Gertner E. Recurrent pulmonary embolism despite inferior vena cava filter placement in patients with the antiphospholipid syndrome. J Clin Rheumatol 2005;11:56-8 DOI |
4 | Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 2006;295:1050-7 DOI ScienceOn |
5 | Klippel JH. Chapter 24. Antiphospholipid Syndrome. In: Klippel JH, editor. Primer on the Rheumatic Diseases. 12th ed. Atlanta, Georgia: Arthritis Foundation; 2001. p. 423-6 |
6 | Cervera R, Asherson RA, Acevedo ML, Gomez-Puerta JA, Espinosa G, De La Red G, et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 2004;63:1312-7 DOI ScienceOn |
7 | Maggiorini M, Knoblauch A, Schneider J, Russi EW. Diffuse microvascular pulmonary thrombosis associated with primary antiphospholipid antibody syndrome. Eur Respir J 1997;10:727-30 |
8 | Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003;349:1133-8 DOI ScienceOn |
9 | Pujol A, Alegria E, Gonzalez J, Ngare Ch, Perez J, Paramo JA. Clinical complications in a series of patients with anticardiolipin antibodies. An Sist Sanit Navar 2003;26:365-72 |
10 | Medina G, Vera-Lastra G, Barile L, Salas M, -Iara LJ. Clinical spectrum of males with primary antiphospholipid syndrome and systemic lupus erythematosus: a comparative study of 73 patients. Lupus 2004; 13:11-6 DOI |
11 | Mackworth-Young C. Primary antiphospholipid syndrome: a distinct entity? Autoimmun Rev 2006;5:70-5 DOI ScienceOn |
12 | Goldhaber SZ. Pulmonary Embolism. N Engl J Med 1998;339:93-104 DOI ScienceOn |
13 | Lockshin MD, Erkan D. Treatment of the antiphospholipid syndrome. N Engl J Med 2003;349:1177-9 DOI ScienceOn |
![]() |